Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination Research Letter

   

Authors:	Chhabra, S.; Szabo, A.; Clurman, A.; McShane, K.; Waters, N.; Eastwood, D.; Samanas, L.; Fei, T.; Armijo, G.; Abedin, S.; Longo, W.; Hari, P.; Hamadani, M.; Shah, N. N.; Runaas, L.; Jerkins, J. H.; van den Brink, M.; Peled, J. U.; Drobyski, W. R.
Title:	Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination
Keywords:	busulfan; mortality; neutropenia; methotrexate; letter; cell proliferation; multiple myeloma; morbidity; hematopoietic stem cell transplantation; chronic myeloid leukemia; monoclonal antibody; myelodysplastic syndrome; prophylaxis; escherichia coli; graft versus host reaction; interleukin 6; allogeneic hematopoietic stem cell transplantation; enterococcus; intestine flora; gastrointestinal tract; tacrolimus; graft vs host disease; influenza; feces analysis; phylogeny; bronchiolitis obliterans; microbial diversity; tocilizumab; antibodies, monoclonal, humanized; humans; human; hierarchical clustering; dysbiosis; mitigation; capnocytophaga sputigena; streptococcus oralis; turnover rate
Journal Title:	Haematologica
Volume:	108
Issue:	1
ISSN:	0390-6078
Publisher:	Ferrata Storti Foundation
Date Published:	2023-01-01
Start Page:	250
End Page:	256
Language:	English
DOI:	10.3324/haematol.2022.281309
PUBMED:	36106394
PROVIDER:	scopus
PMCID:	PMC9827178
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85145424654&doi=10.3324%2fhaematol.2022.281309&partnerID=40&md5=dcd7dc2a467884b7c92f28914e4d5ffd
Notes:	The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF and PubMed record. -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/202550